128 results
Page 4 of 7
8-K
68c0ajwk5
29 Apr 20
Other Events
8:06am
8-K
EX-99.1
dr0dx2xowey7y3ciy
27 Feb 20
Adaptimmune Reports Fourth Quarter / Full Year 2019 Financial Results and Business Update
7:39am
8-K
EX-10.1
jx20lf
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
kum6f2 owvdcc4h7
22 Jan 20
Prospectus supplement for primary offering
5:31pm
424B5
7zd7d7hy13vq 405ou
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
tv6szq1u46d0zzbq27
14 Jan 20
Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
6:17am
8-K
EX-10.1
nn6dqu5nebs d2x
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-99.1
vo1t puddl3ialt6hr
6 Nov 19
Adaptimmune Reports Third Quarter 2019 Financial Results and Business Update
7:35am
8-K
EX-10.1
ozg0tozp
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K
EX-99.1
pwuocska0s2bhk76ecwc
1 Aug 19
Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update
7:23am
8-K
yx1qsw2wfd11qq11fy
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am